Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...

Drug Products: Biologics, Biosimilars and Interchangeables

Drug Products: Biologics, Biosimilars and Interchangeables

Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Correction: How pain intensity and mental disorders shape chronic pain sick leave and quality of life in the general Spanish population.

Scientific reports·2026

Same author

Artificial Liver Support Effectively Removes Immunosuppressive Bile Acids From Circulation in Patients With Severe Liver Failure: A Proof of Concept Study.

Critical care explorations·2026

Same author

Quantitative analysis of murine C-terminal alpha-1-antitrypsin peptides in experimental sepsis and their comparison with human sepsis peptide biomarkers.

Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals·2026

Same author

Are genetically defined "metapopulations" self-evident in YHRD?

Forensic science international. Genetics·2026

Same author

Autoantibodies to IL-1Ra and PGRN in severe COVID-19 are associated with inflammation-induced hyperphosphorylated antigen isoforms.

Nature communications·2026

Same author

MatchY in practice: Factors influencing pedigree-based Y-STR match probabilities.

Forensic science international. Genetics·2026

Same journal

AI in variant analysis: fast track to genetic diagnoses.

Human genetics·2026

Same journal

Combined family-based association and linkage analyses in families affected by attention-deficit hyperactivity disorder.

Human genetics·2026

Same journal

Investigating the shared genetic architecture between selective immunoglobulin A deficiency and autoimmune diseases.

Human genetics·2026

Same journal

ARHI as a key regulator of EMT and metastasis in pancreatic cancer via the Notch-1 pathway.

Human genetics·2026

Same journal

Large-scale mitogenome analysis reveals complex maternal genetic connections between Sino-Tibetan- and Altaic-speaking populations.

Human genetics·2026

Same journal

Correction: A comprehensive and accessible model for co-segregation analysis in BRCA1, BRCA2, and PALB2 variant classification.

Human genetics·2026

See all related articles

Search research articles

Related Experiment Video

Updated: May 31, 2026

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Published on: November 30, 2022

Biobanking and international interoperability: samples.

Michael Kiehntopf¹, Michael Krawczak

¹Institute of Clinical Chemistry and Laboratory Diagnostics, Jena University Hospital, 07740 Jena, Germany. michael.kiehntopf@med.uni-jena.de

|July 16, 2011

Summary

This summary is machine-generated.

International biobank collaborations require careful attention to donor consent and material quality. Bilateral contracts are crucial for navigating legal complexities and ensuring reliable biomaterial transfer for research.

More Related Videos

Establishment of a Clinic-based Biorepository

Establishment of a Clinic-based Biorepository

Published on: May 29, 2017

Biobanking of Human Aqueous and Vitreous Liquid Biopsies for Molecular Analyses

Biobanking of Human Aqueous and Vitreous Liquid Biopsies for Molecular Analyses

Published on: September 11, 2023

Related Experiment Videos

Last Updated: May 31, 2026

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Published on: November 30, 2022

Establishment of a Clinic-based Biorepository

Establishment of a Clinic-based Biorepository

Published on: May 29, 2017

Biobanking of Human Aqueous and Vitreous Liquid Biopsies for Molecular Analyses

Biobanking of Human Aqueous and Vitreous Liquid Biopsies for Molecular Analyses

Published on: September 11, 2023

Area of Science:

Biomedical research
Biobanking
International collaboration

Background:

International biobank collaborations face challenges due to differing legal, ethical, and political frameworks governing sample sharing.
Donor consent imposes significant constraints on the scope and purpose of biomaterial transfer to third parties.

Purpose of the Study:

To highlight key considerations for international sample exchange between biobanks and research partners.
To emphasize the importance of addressing legal uncertainties and quality control in biomaterial transfer.

Main Methods:

Analysis of legal and ethical frameworks impacting international biobank collaborations.
Identification of critical factors in ensuring the quality and integrity of transferred biomaterial.

Main Results:

Defining universal rules for international biomaterial sharing is challenging due to jurisdictional differences.
Legal uncertainties regarding transfer rights, research scope, and intellectual property necessitate bilateral agreements.
Stringent quality control measures are essential throughout the biomaterial lifecycle, from acquisition to storage.

Conclusions:

Bilateral contracts, such as material transfer agreements, are recommended to clarify uncertainties in international sample exchange.
Biobanks must implement robust quality control processes to meet partners' expectations for biomaterial quality.
Contractual warranties for biomaterial type and quality are advisable for acquiring partners.